<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We performed flow cytometric analysis of CD34(+) cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in 22 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and 7 patients with de novo <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) using annexin V-<z:chebi fb="0" ids="37926">FITC</z:chebi>, which binds to exposed phosphatidylserine on apoptotic cells </plain></SENT>
<SENT sid="1" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was significantly increased in low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group (IPSS score â‰¤ 1.0) compared with high-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group (21.33 vs. 7.27%, P &lt; 0.001) and patients with de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (21.33 vs. 7.53%, P &lt; 0.001) </plain></SENT>
<SENT sid="2" pm="."><plain>There was no correlation between <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and patient's age or gender </plain></SENT>
<SENT sid="3" pm="."><plain>Our results confirmed that CD34(+) cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was significantly increased in low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, which was featured as <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>CXCR4 protein expression on CD34(+) cell surface in the low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was lower than high-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (10.42 vs. 16.97, P = 0.014) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> group (10.42 vs. 20.26, P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>But there was no statistical significance between low-grade <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and the control group (P = 0.496) </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, we measured SDF-1 levels in BM plasma from patients by enzyme-linked immunosorbent assay (ELISA), and no difference was found </plain></SENT>
<SENT sid="7" pm="."><plain>We found a negative correlation between <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and CXCR4 expression </plain></SENT>
<SENT sid="8" pm="."><plain>Our data indicate that CXCR4 might be the prognostic marker of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>